NSC |
Compound |
Enrichment |
Correlation |
NSC 755424 |
Null |
0.0203119150246197 |
-0.018540022 |
NSC 756193 |
GSK978744A |
0.0203119150246197 |
-0.072242983 |
NSC 7801 |
Aniline violet (component of) |
0.0203119150246197 |
0.053733241 |
NSC 83459 |
Indole-2,3-dione, 3-(4,4-dimethyl-3-thiosemicarbazone) |
0.0203119150246197 |
-0.17633765 |
NSC 91745 |
9H-Purine, 6-[(1-methyl-4-nitroimidazol-5-yl)thio]-9-.beta.-D-ribofuranosyl-, compd. with ethyl alcohol (4:1) |
0.0203119150246197 |
0.043338065 |
NSC 113951 |
6-Bromotoyocamycin |
0.0209467683758282 |
-0.3639477 |
NSC 127755 |
Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) |
0.0209467683758282 |
-0.11787158 |
NSC 354671 |
1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2- thiazolyl)ethylidene]hydrazide |
0.0209467683758282 |
-0.39841635 |
NSC 363812 |
Tetraplatin |
0.0209467683758282 |
-0.27539533 |
NSC 36437 |
14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) |
0.0209467683758282 |
-0.27064115 |